NCT00773006已完成不适用
Canadian Prospective, Observational Study on the Use of LMWH in the Setting of Percutaneous Coronary Intervention
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 747
- 试验地点
- 1
- 主要终点
- Description of anticoagulant management during PCI and current practices of participating centres will be undertaken
研究概览
简要总结
Advances in mechanical intervention (PCI) and anticoagulation therapy have been the cornerstone of treatment of patients with coronary artery disease. However, the large diversity of approaches to anticoagulation during PCI introduces gaps in knowledge regarding management of cardiac patients. As such, we have initiated a national PCI registry to elucidate anticoagulant choice, dosing strategies, case selection dynamics, and clinical outcomes in the Canadian health care environment.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 or more years of age.
- •Undergoing PCI during treatment with LMWH
- •Provision of written and informed consent
排除标准
- •Language, medical, or psychiatric barriers that preclude understanding of informed consent process.
- •Patients in which the site investigator is unable to comply with completion of study documentation following PCI, i.e. patients with planned transfer to another hospital not participating in the registry.
- •Enrollment in a clinical trial involving another anticoagulant agent.
结局指标
主要结局
Description of anticoagulant management during PCI and current practices of participating centres will be undertaken
时间窗: in-hospital
次要结局
- In-hospital safety outcomes including - major, minor bleeding, requirement for transfusion, death, myocardial infarction (or re-MI), myocardial ischemia requiring urgent revascularization, and major bleeding(in-hospital)
- PCI-related resources utilization during the study period, including cost of PCI and its treatment (e.g. duration of hospital stay, drug costs, costs related to bleeding such as transfusions)(in-hospital)
- In-hospital angiographic complications: no reflow, thrombus, occlusion of collateral branches, distal embolism, coronary dissection, acute closure of the culprit vessel(in-hospital)
研究者
Robert Welsh
Associate Professor
University of Alberta
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary PlaquePlaque, AtheroscleroticCoronary Artery DiseaseNCT02316886Seung-Jung Park1,608
Unknown
2 期
Intracoronary of Nicorandil and Verapamil to Reduce the Occurrence of Periprocedural Myocardial InjuryCoronary Artery DiseaseNCT05399576The First Affiliated Hospital of Zhejiang Chinese Medical University150
招募中
不适用
Cardiovascular Imaging Registry of CanadaCardiovascular DiseasesNCT04367220University of Calgary45,000
Unknown
2 期
BENDITA BEnznidazole New Doses Improved Treatment and AssociationsChagas DiseaseNCT03378661Drugs for Neglected Diseases210
招募中
不适用
Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.Head and Neck CancerUrothelial CarcinomaLiver MetastasesLung MetastasesBreast CancerColorectal CancerLung CancerMelanomaNCT06321640European Institute of Oncology265